Sichuan Kelun-Biotech Subscribes to Wealth Management Products

MT Newswires Live
Jul 01

Sichuan Kelun-Biotech Biopharmaceutical (HKG:6990) said it subscribed to wealth management products offered by China Zheshang Bank and Bank of China, according to a Tuesday filing with the Hong Kong bourse.

The firm agreed to invest 200 million yuan in a structured deposit with China Zheshang Bank for 90 days. The product offers an annualized floating rate of return of 1%, 2%, or 2.15%.

It will invest a further 400 million yuan in a structured deposit with Bank of China for 99 days. The product offers an annualized floating rate of return of 0.60% or 1.90% per annum.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10